K. F. Hanssen

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Bente Kilhovd, Tore Julsrud Berg, K. I. Birkeland et al. · Diabetes Care · 1999 · 265 citations

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

H.‐J. Bangstad, Knut Dahl‐Jørgensen, K. F. Hanssen et al. · Diabetologia · 1994 · 149 citations · Full text

Diabetes Management, Morphological Changes, Renal Disease +9

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

A. Rosenfalck, Per Medbøe Thorsby, Lise Kjems et al. · Acta Diabetologica · 2000 · 113 citations

Metabolic Syndrome, Insulin Signaling, Diabetes Management +9

Early glomerulopathy is present in young, Type 1 (insulin-dependent) diabetic patients with microalbuminuria

H.‐J. Bangstad, Ruth Østerby, Knut Dahl‐Jørgensen et al. · Diabetologia · 1993 · 97 citations · Full text

Glomerular Disease, Glomerulonephritis, Type 1 +10

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Tore Julsrud Berg, Jes Thorn Clausen, Peter A. Torjesen et al. · Diabetes Care · 1998 · 90 citations